Overview
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
Description
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series (less than 15 mins) of eye-tracking measures (e.g., looking time, pupil diameter, oculomotor dynamics), which may be associated with autism outcomes. Investigators will recruit children enrolled in the Tabiri study during or following their 24-month visit.
The Tabiri study is comparing neurodevelopmental (ND) outcomes between 24-month-old CHEU and CHUU.
Eligibility
Inclusion Criteria:
- Children enrolled in the Tabiri study (R01HD104552)
- CHEU or CHUU
- Children ages 24-72 months
- Caregivers of children must speak Kiswahili (local language) or English.
Exclusion Criteria:
- There will be no specific exclusion criteria. We anticipate that a small number of CHEU and CHUU will develop HIV prior to enrollment in the current study; these children will be included and will follow all general study procedures.